Method and apparatus for dermatological treatment and tissue reshaping

Information

  • Patent Grant
  • 10575897
  • Patent Number
    10,575,897
  • Date Filed
    Friday, March 30, 2018
    6 years ago
  • Date Issued
    Tuesday, March 3, 2020
    4 years ago
Abstract
The present invention provides improved methods and apparatus for skin treatment and tissue remodeling. The apparatus includes an array of needles that penetrate the skin and serve as electrodes to deliver radio frequency current or other electrical or optical energy into the tissue being treated, causing thermal damage in controlled patterns. The damaged regions promote beneficial results such as uniform skin tightening by stimulation of wound healing and collagen growth.
Description
FIELD OF THE INVENTION

The present invention is directed to an improved method for treatment of skin and other tissues. More specifically, it is directed to a method of fractional wounding using arrays of needles to damage selected regions of the skin or subdermal tissue and thereby promote beneficial results including skin tightening and tissue remodeling.


BACKGROUND OF THE INVENTION

Skin is primarily made of two layers. The outer layer, or epidermis, has a depth of approximately 100 μm. The inner layer, or dermis, has depth of approximately 3000 μm from the outer surface of the skin and is primarily composed of a network of fibrous protein known as collagen.


There is an increasing demand for repair of skin defects, which can be induced by aging, sun exposure, dermatological diseases, traumatic effects, and the like. Aging skin tends to lose its elasticity, leading to increased formation of wrinkles and sagging. Other causes of undesirable wrinkles in skin include excessive weight loss and pregnancy. There are several well-known surgical approaches to improving the appearance of skin that involve incisions being made in the skin followed by the removal of some tissue and rejoining of the remaining tissue. These surgical approaches include facelifts, brow lifts, breast lifts, and “tummy tucks.” Such approaches have many negative side effects including scar formation, long healing times, displacement of skin from its original location relative to the underlying bone structure, and nonuniform skin tightening.


Many treatments have been developed that use electromagnetic radiation to improve skin defects by inducing a thermal injury to the skin, which results in a complex wound healing response of the skin. This leads to a biological repair of the injured skin and may be accompanied by other desirable effects. Various techniques providing this objective have been introduced in recent years. The different techniques can be generally categorized in two groups of treatment modalities: ablative laser skin resurfacing (“LSR”) and non-ablative collagen remodeling (“NCR”). The first group of treatment modalities LSR, includes causing fairly extensive thermal damage to the epidermis and/or dermis, while the second group, NCR, is designed to avoid thermal damage of the epidermis.


LSR is considered to be an effective laser treatment for repairing skin. In a typical LSR procedure, shown schematically in FIG. 1, a region of the epidermis 100 and a corresponding region of the dermis 110 beneath it are thermally damaged to promote wound healing. Electromagnetic energy 120 is directed towards a region of skin, ablating the skin and removing both epidermal and dermal tissue in region 130. LSR with pulsed CO2 or Er:YAG lasers, which may be referred to in the art as laser resurfacing or ablative resurfacing, is considered to be an effective treatment option for signs of photo aged skin, chronically aged skin, scars, superficial pigmented lesions, stretch marks, and superficial skin lesions. However, patients may experience major drawbacks after each LSR treatment, including edema, oozing, and burning discomfort during first fourteen (14) days after treatment. These major drawbacks can be unacceptable for many patients. A further problem with LSR procedures is that the procedures are relatively painful and therefore generally require an application of a significant amount of analgesia. While LSR of relatively small areas can be performed under local anesthesia provided by injection of an anestheticum, LSR of relatively large areas is frequently performed under general anesthesia or after nerve blockade by multiple injections of anesthetic.


A limitation of LSR is that ablative resurfacing in areas other than the face generally have a greater risk of scarring because the recovery from skin injury within these areas is not very effective. Further, LSR techniques are better suited for correction of pigmentation defects and small lesions than for reducing or eliminating wrinkles.


In an attempt to overcome the problems associated with LSR procedures, several types of NCR techniques has emerged. These techniques are variously referred to in the art as non-ablative resurfacing, non-ablative subsurfacing, or non-ablative skin remodeling. NCR techniques generally utilize non-ablative lasers, flashlamps, or radio frequency current to damage dermal tissue while sparing damage to the epidermal tissue. The concept behind NCR techniques is that thermal damage of the dermal tissue is thought to induce collagen shrinkage, leading to tightening of the skin above, and stimulation of wound healing which results in biological repair and formation of new dermal collagen. This type of wound healing can result in a decrease of structural damage related to photoaging. Avoidance of epidermal damage in NCR techniques decreases the severity and duration of treatment-related side effects. In particular, post-procedural oozing, crusting, pigmentary changes and incidence of infections due to prolonged loss of the epidermal barrier function can usually be avoided by using NCR techniques.


In the NCR method of skin treatment, illustrated schematically in FIG. 2, selective portions of dermal tissue 135 within the dermal layer 110 are heated to induce wound healing without damaging the epidermis 100 above. Selective dermal damage that leaves the epidermis undamaged can be achieved by cooling the surface of the skin and focusing electromagnetic energy 120, which may be a laser beam, onto dermal region 135 using lens 125. Other strategies are also applied using nonablative lasers to achieve damage to the dermis while sparing the epidermis in NCR treatment methods. Nonablative lasers used in NCR procedures generally have a deeper dermal penetration depth as compared to ablative lasers used in LSR procedures. Wavelengths in the near infrared spectrum can be used. These wavelengths cause the non-ablative laser to have a deeper penetration depth than the very superficially-absorbed ablative Er:YAG and CO2 lasers. Examples of NCR techniques and apparatus are disclosed by Anderson et al. in U.S. Patent Publication No. 2002/0161357.


While it has been demonstrated that these NCR techniques can assist in avoiding epidermal damage, one of the major drawbacks of these techniques is their limited efficacies. The improvement of photoaged skin or scars after the treatment with NCR techniques is significantly smaller than the improvements found when LSR ablative techniques are utilized. Even after multiple treatments, the clinical improvement is often far below the patient's expectations. In addition, clinical improvement is usually several months delayed after a series of treatment procedures. NCR is moderately effective for wrinkle removal and is generally not effective for dyschromia. One advantage of NCR is that it does not have the undesirable side effects that are characteristic of the LSR treatment, such as the risk of scarring or infection.


Another limitation of NCR procedures relates to the breadth of acceptable treatment parameters for safe and effective treatment of dermatological disorders. The NCR procedures generally rely on an optimum coordination of laser energy and cooling parameters, which can result in art unwanted temperature profile within the skin leading to either no therapeutic effect or scar formation due to the overheating of a relatively large volume of the tissue.


Another approach to skin tightening and wrinkle removal involves the application of radio frequency (“RF”) electrical current to dermal tissue via a cooled electrode at the surface of the skin. Application of RF current in this noninvasive manner results in a heated region developed below the electrode that damages a relatively large volume of the dermis, and epidermal damage is minimized by the active cooling of the surface electrode during treatment. This treatment approach can be painful, and can lead to short-term swelling of the treated area. Also, because of the relatively large volume of tissue treated and the need to balance application of RF current with surface cooling, this RF tissue remodeling approach does not permit fine control of damage patterns and subsequent skin tightening. This type of RF technique is monopolar, relying on a remote grounding of the patient to complete the current flow from the single electrode. The current in monopolar applications must flow through the patient's body to the remote ground, which can lead to unwanted electrical stimulation of other parts of the body, in contrast, bipolar instruments conduct the current between two relatively nearby electrodes through a more localized pathway.


In view of the shortcomings of the above methods of dermatological treatment and tissue remodeling, there is a need to provide a procedure and apparatus that combine safe and effective treatment for tissue remodeling, skin tightening, and wrinkle removal with minimal side effects, such as intra-procedural discomfort, post-procedural discomfort, lengthy healing time, and post-procedural infection.


Citation or identification of any document in this application is not an admission that such document is available as prior art to the present invention.


SUMMARY OF THE INVENTION

It is therefore one of the objects of the present invention to provide an apparatus and method that combines safe and effective treatment for an improvement of dermatological disorders with minimum side effects. Another object of the present invention is to provide an apparatus and method that promotes skin tightening and wrinkle removal by creation of a pattern of small localized regions of thermal damage within the dermis. Still another object of the present invention is to provide a method and apparatus for skin tightening or other foul's of tissue remodeling by using an array of electrode needles to controllably deliver electrical or thermal energy to predetermined locations within the dermis or other tissue.


These and other objects can be achieved with an exemplary embodiment of the apparatus and method according to the present invention, in which portions of a target area of tissue are be subjected electromagnetic radiation, such as radio frequency pulses, or thermal energy. Electromagnetic radiation is directed to portions of a target area within the skin or deeper tissue using minimally invasive methods, causing fractional wounding of the portions of the target area. The electromagnetic radiation may be generated by an electromagnetic radiation source, which is configured to deliver heat, radio frequency pulses, electrical current, or the like to a plurality of target areas.


In yet another exemplary embodiment according to the present invention, an electromagnetic radiation source is configured to generate electromagnetic radiation, and a delivery device comprising an array of needles, coupled to the electromagnetic radiation source, is configured to penetrate the skin to a desired depth to deliver the electromagnetic radiation directly to a plurality of target areas.


One method in accordance with the present invention comprises inserting an array of needles into a region of skin to a predetermined depth. Radio frequency pulses of electrical current are then applied to one or more of the needles, which can function as electrodes in monopolar or bipolar modes to create regions of thermal damage and/or necrosis in the tissue surrounding the tips of the needles.


In an alternate aspect of the invention, one or more of the needles in the array may be hollow and used to deliver small amounts of analgesic or anesthetic into the region of skin being treated. These hollow needles may be interspersed among the electrode needles in the array, and they may also function as electrodes.


In another embodiment of the invention, the electrode needles may also be connected to a second source of electrical current in the milliampere range. Detection of a nerve close to any of the inserted needles of the array is achieved by sequential application of small currents to the needles in the array and observation of any visible motor response. If a nerve is detected, the nearby needle or needles can be deactivated during the subsequent application of RF current to other electrode needles in the array to avoid damaging the nerve.


In yet another embodiment of the invention, the methods and apparatus described herein can be used to heat portions of cartilage, such as that located in the nose, using a minimally invasive technique, allowing reshaping of the pliant heated cartilage to a desired form.


A further understanding of the nature and advantages of the present invention will become apparent by reference to the remaining portions of the specification and drawings.





BRIEF DESCRIPTION OF THE DRAWINGS

The following detailed description, given by way of example, but not intended to limit the invention solely to the specific embodiments described, may best be understood in conjunction with the accompanying drawings, in which:



FIG. 1 is a schematic drawing of a cross section of a tissue treated using the ASR method.



FIG. 2 is a schematic drawing of a cross section of a tissue treated using the NSR method.



FIG. 3 is a schematic illustration of an apparatus for conducting tissue reshaping using electromagnetic energy according to one embodiment of the present invention.



FIG. 4 is a schematic illustration of portions of an apparatus for conducting tissue reshaping according to one embodiment of the present invention.





Throughout the drawings, the same reference numerals and characters, unless otherwise stated, are used to denote like features, elements, components, or portions of the illustrated embodiments. Moreover, while the present invention will now be described in detail with reference to the Figures, it is done so in connection with the illustrative embodiments and is not limited by the particular embodiments illustrated in the Figures.


DETAILED DESCRIPTION OF THE INVENTION

The present invention relates to methods and apparatus for improvement of skin defects including, but not limited to, wrinkles, stretch marks, and cellulite. In one embodiment, skin tightening or tissue remodeling is accomplished by creating a distribution of regions of necrosis, fibrosis, or other damage in the tissue being treated. The tissue damage is achieved by delivering localized concentrations of electrical current that is converted into heat in the vicinity of the tips of the electrode needles. Inducing regions of local thermal damage within the dermis results in an immediate shrinking of collagen, leading to beneficial skin tightening response. Additionally, the thermal damage tends to stimulate the formation of new collagen, which makes the local skin tissue fuller and gradually leads to additional skin tightening and reduction of wrinkles.


In an exemplary embodiment of the present invention, tissue treatment apparatus 300 shown in FIG. 3 may be used to create regions of damage within the tissue being treated. The tissue reshaping apparatus may comprise a plurality of needles 350 attached to a base 310. The base is attached to housing 340 or formed as a part of the housing. A source of RF current 320 is electrically connected to each of the needles 350. A control module 330 permits variation of the characteristics of the RF electrical current, which can be supplied individually to one or more of the needles. Optionally, energy source 320 and/or control module 330 may be located outside of the housing.


In one exemplary embodiment, the energy source 320 is a radio frequency (RF) device capable of outputting signals having frequencies in a desired range. In another exemplary embodiment, the energy source is capable of outputting an AC or DC electric current. The control module 330 provides application-specific settings to the energy source 320. The energy source 320 receives these settings, and generates a current directed to and from specified needles for selectable or predetermined durations, intensities, and sequences based on these settings.


In yet another embodiment of the present invention, a spacer substrate 315 containing a pattern of small holes through which the array of needles protrudes may optionally be provided between the base 310 and the surface of the skin 306. This spacer substrate may be used to provide mechanical stability to the needles. Optionally, this substrate may be movably attached to the base 310 or housing 340 and adjustable with respect to base 310, supporting the array of needles to control the depth of the needles protruding from the lower surface 316 of spacer substrate 315, and thus controlling the depth to which the needles are inserted into the skin.


In practicing a method in accordance with the present invention, the sharp distal ends of needles 350 pierce the surface 306 of skin tissue 305 and are inserted into the tissue until the bottom surface 316 of spacer substrate 315 (or the bottom surface 311 of base 310 if a spacer substrate 315 is not used) contacts the surface 306 of the skin 305. This configuration permits reliable insertion of the array of needles to a predetermined depth within the tissue being treated. Control module 330 is then configured to deliver controlled amounts of RF current to one or more needles 350.


Base 310 and/or spacer substrate 315, if used, can be planar or they may have a bottom surface that is contoured to follow the shape of the region of tissue being treated. This permits penetration of the needle array to a uniform depth within the targeted tissue even if the surface of the skin is not planar, e.g., along the eye sockets.


In another embodiment, base 310 and/or a spacer substrate 315, if used, may be cooled by any suitable means (such as by embedded conduits containing circulating coolant or by a Peltier device) to cool the surface of the skin when the needle array penetrates the skin to reduce or eliminate pain. The surface region of the skin being treated and/or the needles themselves may also be precooled by separate means, including convective or conductive means, prior to penetration of the skin by the array of needles.


In a preferred embodiment of the present invention, the shafts of conductive needles 350 are electrically insulated except for the portion of the needle near the tip. In the apparatus of FIG. 3, application of RF current to the needles 350 causes heating in the exposed tip region, inducing thermal damage regions 370 around the tip of each needle. Thermal damage regions 370 result from operation of the apparatus in monopolar configuration, in which a remote grounding electrode, not shown in FIG. 3, is attached to a remote part of the patient's body to complete the circuit of electricity conveyed to needles 350 by energy source 320. In this monopolar configuration, RF current causes heating of the tip regions of the needles 350, generating thermal damage in tissue regions 370 adjacent to the needle tips that are approximately spherical or slightly elongated in shape.


In one embodiment of the invention, current may be delivered simultaneously to all needles in the array to produce a pattern of thermal damage around the tip of each needle. In alternative embodiments, control module 330 and energy source 320 can be configured to supply electrical current to individual needles, to specific groups of needles within the array, or to any combination of individual needles in any desired temporal sequence. Providing current to different needles at different times during treatment (instead of heating all needles in the array at once) may help to avoid potential local electrical or thermal interactions among needles that can lead to excessive local damage.


In yet another embodiment of the present invention one or more vibrating means, such as a piezoelectric transducer or a small motor with an eccentric weight fixed to the shaft, may be mechanically coupled to housing 340 and/or base 310 that supports the array of needles 350. Vibrations conductively induced in needles 350 by such vibrating means can facilitate the piercing of the skin by the needle tips and subsequent insertion of the needles into the tissue. The vibrating means can have an amplitude of vibration in the range of about 50-500 μm or, more preferably, between about 100-200 μm. The frequency of the induced vibrations can be from about 10 hz to about 10 khz, more preferably from about 500 hz to about 2 khz, and even more preferably about 1 khz. The particular vibration parameters chosen may depend on the size and material of the needles, the number of needles in the array, and the average spacing of the needles. The vibrating means may further comprise an optional controller capable of adjusting the amplitude and/or frequency of the vibrations.


Additional details and embodiments of the present invention are shown in FIG. 4. Conductive needles 410 and 415 are shown attached to base 310. Insulation 420 covers the shaft of needles 410 and 415 protruding from base 310 except for the region near the lower tip, and electrically insulates each conductive needle shaft from surrounding tissue 305. Electrical conductors 430 and 431, which may be wires or the like, extend from an upper portion of needles 410 and 415 respectively, and are connected to the energy source (not shown here). Suitable insulating materials for insulation 420 include, but are not limited to, Teflon®, polymers, glasses, and other nonconductive coatings. A particular material may be chosen as an insulator to facilitate penetration and insertion of needles 410 and 415 into tissue 305.


Needles 410 and 415 are shown operating in bipolar mode in another embodiment of the present invention. Needle 410 is a positive electrode delivering RF or other current to the tip region of the needle from the energy source via conductor 430. Needle 415 functions as a grounding electrode that is connected to the ground of the energy source via conductor 431. In this configuration the applied current will travel through the tissue between the tips of needles 410 and 415, generating an elongated region of thermal damage 425 around and between the tips of the two needles.


An elongated region of damaged tissue 425 can be created between any two adjacent or nearby needles in the array through proper configuration of control module 330 and energy source 320. In an embodiment of the present invention, elongated damage regions 425 are formed between several pairs of needles within the array of needles to form a desired damage pattern in the tissue 305. The regions of thermal damage 325 created in bipolar operation of the apparatus may be formed simultaneously or, alternatively, sequentially, using any combinations of proximate needles in the array to form each region. A wide variety of thermal damage patterns can be created using a single array of needles through appropriate configuration of energy source 320 and control module 330 to deliver predetermined amounts of current between selected pairs of needles. This apparatus thus allows for the creation of complex damage patterns within the tissue 305 that may be macroscopically elongated in preferred directions to produce anisotropic shrinkage and reshaping.


In practicing the methods and apparatus of the present invention, the needles can have a width of about 500-1000 μm or preferably about 700-800 μm. Needles less than 500 μm in diameter may also be used if they are mechanically strong enough. Needles thicker than about 1000 μm in diameter may be undesirable because of the difficulty in forcing larger needles to penetrate the skin and because of the increased propensity for pain and scarring. The length of the needles extending into the skin will depend on the targeted depth for damaging the tissue. A typical depth for targeting collagen in the dermis is about about 1500-2000 μm, although shallower or deeper distances may be preferred for different treatments and regions of the body being treated. Needles within a single array may protrude by different lengths from the base 310 or spacer substrate 315. This will cause the tips of the needles to be positioned at different depths within the tissue being treated, and allow creation of damaged tissue at more than one depth. This variation in needle depth can achieve formation of damaged tissue over a larger volume within the tissue being treated.


The needle arrays may have any geometry appropriate for the desired treatment being performed. The spacing between adjacent needles is preferably greater than about 1 mm apart, and may be as large as about 2 cm. The spacing between needles in an array need not be uniform, and can be closer in areas where a greater amount of damage or more precise control of damage in the target area of tissue is desired. In one embodiment, the array of needles may comprise pairs of needles separated from adjacent pairs by larger distances. This geometry may be well-suited for inducing damage in bipolar mode between pairs of needles. Needles may also be arranged in a regular or near-regular square or triangular array. In any array geometry, the pattern of damage and resultant tissue reshaping may be controlled with some precision by adjusting the intensity and duration of power transmitted to single needles or pairs of needles.


The amount of energy directed to a given needle will vary depending on the tissue being treated and the desired extent of thermal damage to induce. For typical needle spacings noted above, the energy source should be configured to deliver about 1-100 mJ per needle or pair of needles in the array. It may be preferable to initially use lower amounts of energy and perform two or more treatments over the same target area to better control the damage patterns and extent of reshaping.


In yet another embodiment of the present invention, one or more of the needles in the array may be hollow, such as needle 440 in FIG. 4. Center channel 450 may be used to deliver a local analgesic such as lidocaine 2% solution from a source (not shown) located within or above base 310 into the tissue 305 to reduce or eliminate pain caused by the thermal damage process.


In yet another embodiment of the present invention, hollow needle 440 is bifunctional, capable of conducting RF current or other energy via conductor 432 and also capable of delivering a local analgesic or the like through center channel 450. Similar to needles 410 and 415, bifunctional needle 440 has insulation 445 covering the shaft extending from base 310 except for the region near the lower tip. Analgesic may be supplied to the tissue either before or during application of RF or other current to the needle 450.


In one embodiment of the invention, one or more of the needles in the array may be bifunctional like needle 440. Alternatively, one or more needles may be hollow and optionally nonconductive, suitable only for delivering a local analgesic or the like. The array of needles used for a given application may comprise any combination of solid electrodes, bifunctional needles, or hollow nonconductive needles. For example, one type of needle array may comprise pairs of electrode needles operating in bipolar mode, with a hollow needle located between each pair. In this configuration, the hollow needle can deliver analgesic to the tissue between the tips of the electrode needles prior to applying current to the electrodes and causing thermal damage in the numbed tissue.


In yet another embodiment of the present invention, one or more of the needles in the array may be further connected to an electronic detection apparatus and perform the additional function of a probe to detect the presence of a nerve near the tip. The electronic detection apparatus may comprise a source of electrical current in the milliampere range and control means to send small currents on the order of a milliamp to specific needles in the array. Detection of a nerve close to any of the inserted needles of the array is performed by sequential application of small currents to the needles in the array and observation of any visible motor response. If a nerve is detected, control module 330 can be configured to deactivate the needle or needles close to the nerve during the subsequent treatment to avoid damaging the nerve. A nerve detection method based on principles similar to those described herein is disclosed by Urmey et al. In Regional Anesthesia and Pain Medicine 27:3 (May-June) 2002, pp. 261-267.


In still another embodiment, one or more of the needles may be hollow, and a light fiber or light guide is inserted into the hollow needle such that one end of it extends to or slightly protrudes from the needle tip. The other end of the light fiber or light guide in communication with a source of optical energy. Optical energy supplied to the tip of the light guide or light fiber may then be used to heat the tip, which then heats the surrounding tissue, i.e., the target area, to cause fractional wounding at the needle tip. An array of needles used in accordance with the present invention may comprise a mix of electrode needles and light-guide needles. Alternatively, each needle may carry a light guide and all of the energy used to cause thermal damage may be generated by the optical energy source instead of using RF or other electrical current. A portion of the light guide or light fiber, such as the portion at the tip of the needle, may be configured to absorb energy and facilitate conversion of the optical energy to heat. In these embodiments, the optical energy source may comprise, but is not limited to, a diode laser, a diode-pumped solid state laser, an Er:YAG laser, a Nd:YAG laser, an argon-ion laser, a He—Ne laser, a carbon dioxide laser, an eximer laser, or a ruby laser. The optical energy conveyed by a light guide or light fiber may optionally be continuous or pulsed.


Treatments performed in accordance with the present invention may be used to target collagen in the dermis. This can lead to immediate tightening of the skin and reduction of wrinkles overlying the damaged tissue arising from contraction of the heated collagen. Over time, the thermal damage also promotes the formation of new collagen, which serves to smooth out the skin even more.


An alternative application of the methods of the present invention may be to reduce or eliminate the appearance of cellulite. To achieve this, the arrays of needles are configured to target the dermis and optionally the upper layer of subcutaneous fat directly. Creating dispersed patterns of small thermally-damaged regions in these layers can tighten the networked collagen structure and suppress the protrusion of the subcutaneous fat into the dermal tissue that causes cellulite.


Yet another application of the methods and apparatus of the present invention is to reshape cartilage. It is known that cartilage softens upon heating, and heating it to about 70 degrees C. can soften the cartilage sufficiently to permit reshaping that persists upon cooling. Currently, specialized lasers are used to heat and soften cartilage in the nasal passages for reshaping. Using the methods and apparatus described herein, cartilage can be targeted by art array of needles and heated in a suitably gradual way, using lower power densities and longer times, to provide relatively uniform heating. Shaping of the cartilage is thus possible using a minimally invasive technique that can be used where laser heating may not be feasible.


Any of the thermal damaging and tissue reshaping methods practiced in accordance with the present invention may be performed in a single treatment, or by multiple treatments performed either consecutively during one session or at longer intervals over multiple sessions. Individual or multiple treatments of a given region of tissue can be used to achieve the appropriate thermal damage and desired cosmetic effects.

Claims
  • 1. A skin treatment device comprising: a housing configured to support a plurality of needles arranged for insertion through a dermal layer of skin and into a subcutaneous fat layer, the plurality of needles being attached to a base, the plurality of needles being further configured for application of radio frequency (RF) energy from a RF energy source; anda control module for controlling delivery of the RF energy from the RF energy source to the plurality of needles to induce thermal damage by the RF energy in the subcutaneous fat layer when the needles are inserted therein, wherein the controlled delivery of the RF energy is configured to cause a pattern of fractional thermal damage having thermally damaged regions in the subcutaneous fat layer.
  • 2. The device of claim 1, wherein the plurality of needles are associated with each other in groups of bipolar pairs, wherein the control module is configured to control the delivery of the RF energy to bipolar pairs to cause areas of non-ablative damage within the subcutaneous fat layer, and wherein each area of non-ablative damage is associated with each bipolar pair of the plurality of needles.
  • 3. The device of claim 1, wherein at least one of the plurality of needles is a mono-polar needle.
  • 4. The device of claim 1, wherein the control module is further configured to receive a selection of an application-specific setting for the RF energy source to cause the RF energy source to vary at least one of a duration, intensity, and sequence of the RF energy transmitted to the plurality of needles based on the selected setting.
  • 5. The device of claim 1, wherein at least two of the plurality of needles have differing lengths.
  • 6. The device of claim 1, further comprising a cooler for cooling a surface of the skin when inserting the plurality of needles through the dermal layer of skin.
  • 7. The device of claim 1, wherein at least one of the plurality of needles is a hollow needle, and further comprising a delivery mechanism for delivering an analgesic via the hollow needle to tissue surrounding a tip of the hollow needle.
  • 8. The device of claim 1, further comprising a detector for detecting a presence of a nerve near a tip of at least one of the plurality of needles.
  • 9. The device of claim 1, further comprising a spacer having holes through which the needles are configured to move.
  • 10. The device of claim 1, wherein the control module is configured to control RF energy delivery in order to induce damaged regions surrounding each tip of each of the plurality of needles, with undamaged regions between the damaged regions.
  • 11. The device of claim 1, wherein each of the needles has a tip, and wherein the control module is configured to cause at least two adjacent regions of thermal damage, with a small localized area of thermal damage surrounding each tip.
  • 12. A skin treatment device, comprising: a housing configured to support a plurality of needles arranged for insertion through a dermal layer of skin and into a subcutaneous fat layer of skin, the plurality of needles being attached to a base, the plurality of needles being further configured for application of radio frequency (RF) energy from a RF energy source; anda control module for controlling delivery of the-RF energy from the RF energy source to the plurality of needles to cause a pattern of fractional damage to be produced in the subcutaneous fat layer in a vicinity of the tips of the needles,wherein delivery of the RF energy is controlled to cause a pattern of regions of thermal damage within the subcutaneous fat layer, and wherein at least two adjacent regions of thermal damage have an undamaged region therebetween.
  • 13. The device of claim 12, wherein the control module is configured to cause necrosis in the subcutaneous fat layer.
  • 14. A skin treatment device comprising: a housing configured to support a plurality of needles arranged for insertion through a dermal layer of skin and into a subcutaneous fat layer, the plurality of needles being attached to a base and arranged in a group of bipolar pairs, the plurality of needles being further configured for application of radio frequency (RF) energy from a RF energy source; anda control module for controlling delivery of the RF energy from the RF energy source to the plurality of needles to induce a pattern of fractional damage by the RF energy in the subcutaneous fat layer when the needles are inserted therein,wherein the pattern of fractional damage includes thermally-damaged regions between tips of needles of the bipolar pairs, and undamaged regions between bipolar pairs of needles in the group.
  • 15. The device of claim 14, wherein the control module is configured to cause the damaged regions to be elongated between the needles of the bipolar pairs.
  • 16. The device of claim 14, wherein the control module is configured to cause necrosis.
  • 17. A skin treatment device comprising: a housing configured to support a plurality of monopolar needles arranged for insertion through a dermal layer of skin and into a subcutaneous fat layer, the plurality of monopolar needles being attached to a base and configured for application of radio frequency (RF) energy from a RF energy source; anda control module for controlling delivery of the RF energy from the RF energy source to the plurality of needles to induce a pattern of fractional damage by the RF energy in the subcutaneous fat layer when the needles are inserted therein,wherein the pattern of fractional damage includes thermally-damaged regions in a vicinity of each tip of each of the plurality of monopolar needles, and undamaged regions between the damaged regions.
  • 18. The device of claim 17, wherein the control module is configured to cause necrosis.
RELATED APPLICATIONS

The present application is a continuation of U.S. patent application Ser. No. 15/844,597 filed on Dec. 17, 2017, which is a continuation of U.S. patent application Ser. No. 14/725,976 filed on May 29, 2015, now U.S. Pat. No. 9,877,778, issued on Jan. 30, 2018, which is a continuation of U.S. patent application Ser. No. 12/914,201 filed on Oct. 28, 2010, now U.S. Pat. No. 9,095,357, issued on Aug. 4, 2015, which has a continuation U.S. patent Ser. No. 14/458,644, filed Aug. 13, 2014, now U.S. Pat. No. 9,510,899 issued Dec. 6, 2016 and is a divisional of U.S. patent application Ser. No. 11/098,030 filed on Apr. 1, 2005, now U.S. Pat. No. 7,824,394, issued on Nov. 2, 2010. The present application and all applications addressed above claims benefit to U.S. Provisional Application No. 60/558,476 filed on Apr. 1, 2004. The entire disclosures of such applications are incorporated herein by reference. The foregoing applications, and all documents cited therein or during their prosecution (“appln cited documents”) and all documents cited or referenced in the appln cited documents, and all documents cited or referenced herein (“herein cited documents”), and all documents cited or referenced in herein cited documents, together with any manufacturer's instructions, descriptions, product specifications, and product sheets for any products mentioned herein or in any document incorporated by reference herein, are hereby incorporated herein by reference, and may be employed in the practice of the invention.

US Referenced Citations (349)
Number Name Date Kind
1781362 Joseph et al. Nov 1930 A
1943543 Mcfadden et al. Jan 1934 A
3505993 Lewes et al. Apr 1970 A
3595231 Pistor et al. Jul 1971 A
3964482 Gerstel et al. Jun 1976 A
3987795 Morrison Oct 1976 A
4397314 Vaguine Aug 1983 A
4448198 Turner May 1984 A
4522210 Simonin Jun 1985 A
4598709 Smith et al. Jul 1986 A
4679561 Doss Jul 1987 A
4733660 Itzkan Mar 1988 A
4920968 Takase May 1990 A
4969468 Byers et al. Nov 1990 A
4985027 Dressel Jan 1991 A
5000752 Hoskin et al. Mar 1991 A
5102410 Dressel Apr 1992 A
5122137 Lennox Jun 1992 A
5137530 Sand Aug 1992 A
5281216 Klicek Jan 1994 A
5284154 Raymond et al. Feb 1994 A
5312395 Tan et al. May 1994 A
5339347 Slatkin et al. Aug 1994 A
5425752 VuNguyen Jun 1995 A
5439440 Hofmann Aug 1995 A
5441499 Fritzsch Aug 1995 A
5449378 Schouenborg Sep 1995 A
5458596 Lax et al. Oct 1995 A
5484400 Edwards et al. Jan 1996 A
5569242 Lax et al. Oct 1996 A
5582184 Erickson et al. Dec 1996 A
5588960 Edwards et al. Dec 1996 A
5599342 Hsia et al. Feb 1997 A
5599345 Edwards et al. Feb 1997 A
5620481 Desai et al. Apr 1997 A
5660836 Knowlton Aug 1997 A
5674267 Mir et al. Oct 1997 A
5683384 Gough et al. Nov 1997 A
5697281 Eggers et al. Dec 1997 A
5697882 Eggers et al. Dec 1997 A
5697909 Eggers et al. Dec 1997 A
5702359 Hofmann et al. Dec 1997 A
5707349 Edwards Jan 1998 A
5755753 Knowlton May 1998 A
5782827 Gough et al. Jul 1998 A
5797904 Smith Aug 1998 A
5797926 Mehl, Sr. Aug 1998 A
5807385 Keller Sep 1998 A
5810801 Anderson et al. Sep 1998 A
5814040 Nelson et al. Sep 1998 A
5817092 Behl Oct 1998 A
5843078 Sharkey Dec 1998 A
5861002 Desai Jan 1999 A
5868744 Willmen Feb 1999 A
5871524 Knowlton Feb 1999 A
5873855 Eggers et al. Feb 1999 A
5879376 Miller Mar 1999 A
5919219 Knowlton Jul 1999 A
5928158 Aristides Jul 1999 A
5948011 Knowlton Sep 1999 A
5954710 Paolini et al. Sep 1999 A
5964726 Korenstein et al. Oct 1999 A
5976129 Desai Nov 1999 A
5983135 Avrahami Nov 1999 A
5993434 Dev et al. Nov 1999 A
6009347 Hofmann Dec 1999 A
6010500 Sherman et al. Jan 2000 A
6014584 Hofmann et al. Jan 2000 A
6022316 Eppstein et al. Feb 2000 A
6027495 Miller Feb 2000 A
6048352 Douglas et al. Apr 2000 A
6068629 Haissaguerre et al. May 2000 A
6068650 Hofmann et al. May 2000 A
6068653 LaFontaine May 2000 A
6071280 Edwards et al. Jun 2000 A
6077257 Edwards et al. Jun 2000 A
6081749 Ingle et al. Jun 2000 A
6106516 Massengill Aug 2000 A
6120493 Hofmann Sep 2000 A
6120519 Weber et al. Sep 2000 A
6126657 Edwards et al. Oct 2000 A
6139545 Utley et al. Oct 2000 A
6143019 Motamedi et al. Nov 2000 A
6148232 Avrahami Nov 2000 A
6162211 Tankovich et al. Dec 2000 A
6162220 Nezhat Dec 2000 A
6169926 Baker Jan 2001 B1
6197020 ODonnell, Jr. Mar 2001 B1
6197022 Baker Mar 2001 B1
6206873 Paolini et al. Mar 2001 B1
6208893 Hofmann Mar 2001 B1
6210402 Olsen et al. Apr 2001 B1
6212433 Behl Apr 2001 B1
6216034 Hofmann et al. Apr 2001 B1
6216704 Ingle Apr 2001 B1
6228078 Eggers et al. May 2001 B1
6228082 Baker et al. May 2001 B1
6233482 Hofmann et al. May 2001 B1
6241753 Knowlton Jun 2001 B1
6277116 Utely Aug 2001 B1
6278895 Bernard Aug 2001 B1
6296636 Cheng et al. Oct 2001 B1
6309387 Eggers et al. Oct 2001 B1
6311090 Knowlton Oct 2001 B1
6312428 Eggers et al. Nov 2001 B1
6312612 Sherman et al. Nov 2001 B1
6328033 Avrahami Dec 2001 B1
6334856 Allen et al. Jan 2002 B1
6347251 Deng Feb 2002 B1
6350276 Knowlton Feb 2002 B1
6355030 Aldrich et al. Mar 2002 B1
6355031 Edwards et al. Mar 2002 B1
6355054 Neuberger Mar 2002 B1
6375672 Aksan et al. Apr 2002 B1
6377854 Knowlton Apr 2002 B1
6377855 Knowlton Apr 2002 B1
6379324 Gartstein et al. Apr 2002 B1
6381497 Knowlton Apr 2002 B1
6381498 Knowlton Apr 2002 B1
6387380 Knowlton May 2002 B1
6405090 Knowlton Jun 2002 B1
6413255 Stern Jul 2002 B1
6416514 Ein-Gal Jul 2002 B1
6416531 Chen Jul 2002 B2
6425912 Knowlton Jul 2002 B1
6427089 Knowlton Jul 2002 B1
6428504 Riaziat et al. Aug 2002 B1
6430446 Knowlton Aug 2002 B1
6438424 Knowlton Aug 2002 B1
6440121 Weber et al. Aug 2002 B1
6453202 Knowlton Sep 2002 B1
6461378 Knowlton Oct 2002 B1
6463331 Edwards Oct 2002 B1
6470216 Knowlton Oct 2002 B1
6471698 Edwards et al. Oct 2002 B1
6482204 Lax et al. Nov 2002 B1
6503231 Prausnitz et al. Jan 2003 B1
6524308 Muller et al. Feb 2003 B1
6530922 Cosman et al. Mar 2003 B2
6556869 Leonard et al. Apr 2003 B1
6562054 Weber et al. May 2003 B1
6572639 Ingle et al. Jun 2003 B1
6587730 Bernabei Jul 2003 B2
6589235 Wong et al. Jul 2003 B2
6597946 Avrahami et al. Jul 2003 B2
6605079 Shanks et al. Aug 2003 B2
6605080 Altshuler et al. Aug 2003 B1
6611706 Avrahami et al. Aug 2003 B2
6615079 Avrahami Sep 2003 B1
6628990 Habib et al. Sep 2003 B1
6629974 Penny et al. Oct 2003 B2
6632193 Davison et al. Oct 2003 B1
6654636 Dev et al. Nov 2003 B1
6678556 Nolan et al. Jan 2004 B1
6678558 Dimmer et al. Jan 2004 B1
6690959 Thompson Feb 2004 B2
6702808 Kreindel Mar 2004 B1
6708060 Avrahami et al. Mar 2004 B1
6711435 Avrahami Mar 2004 B2
6723090 Altshuler et al. Apr 2004 B2
6723091 Goble et al. Apr 2004 B2
6723092 Brown et al. Apr 2004 B2
6743211 Prausnitz et al. Jun 2004 B1
6749604 Eggers et al. Jun 2004 B1
6749624 Knowlton Jun 2004 B2
6766202 Underwood et al. Jul 2004 B2
6770071 Woloszko et al. Aug 2004 B2
6837335 Jankowski Jan 2005 B2
6840954 Dietz Jan 2005 B2
6882885 Levy, Jr. et al. Apr 2005 B2
6889089 Behl et al. May 2005 B2
6889090 Kreindel May 2005 B2
6890332 Truckai et al. May 2005 B2
6896674 Woloszko et al. May 2005 B1
6896675 Leung et al. May 2005 B2
6905497 Truckai et al. Jun 2005 B2
6918907 Kelly et al. Jul 2005 B2
6920883 Bessette et al. Jul 2005 B2
6939344 Kreindel Sep 2005 B2
6991631 Woloszko et al. Jan 2006 B2
6997923 Anderson et al. Feb 2006 B2
7006874 Knowlton et al. Feb 2006 B2
7008421 Daniel et al. Mar 2006 B2
7013179 Carter et al. Mar 2006 B2
7022121 Stern et al. Apr 2006 B2
7025765 Balbierz et al. Apr 2006 B2
7028485 Mee Apr 2006 B1
7054685 Dimmer May 2006 B2
7056318 Black Jun 2006 B2
7060061 Altshuler et al. Jun 2006 B2
7070597 Truckai et al. Jul 2006 B2
7090670 Sink Aug 2006 B2
7094252 Koop Aug 2006 B2
7101387 Garabedian et al. Sep 2006 B2
7115123 Knowlton et al. Oct 2006 B2
7115124 Xiao Oct 2006 B1
7141049 Stern et al. Nov 2006 B2
7189230 Knowlton Mar 2007 B2
7211083 Chornenky et al. May 2007 B2
7217265 Hennings et al. May 2007 B2
7223264 Daniel et al. May 2007 B2
7229436 Stern et al. Jun 2007 B2
7238183 Kreindel Jul 2007 B2
7251531 Mosher et al. Jul 2007 B2
7278991 Morris et al. Oct 2007 B2
7297143 Woloszko et al. Nov 2007 B2
7306591 Thomas et al. Dec 2007 B2
7317949 Morrison et al. Jan 2008 B2
7327395 Nobuoka Feb 2008 B2
7331953 Manstein et al. Feb 2008 B2
7344533 Pearson et al. Mar 2008 B2
7416550 Protsenko et al. Aug 2008 B2
7422586 Morris et al. Sep 2008 B2
7494488 Weber Feb 2009 B2
7824394 Manstein Nov 2010 B2
7824395 Chan et al. Nov 2010 B2
7938824 Chornenky et al. May 2011 B2
7942153 Manstein et al. May 2011 B2
7967839 Flock et al. Jun 2011 B2
8268332 Manstein Sep 2012 B2
8608737 Mehta et al. Dec 2013 B2
8882753 Mehta et al. Nov 2014 B2
9095357 Manstein Aug 2015 B2
9351792 Manstein et al. May 2016 B2
9877778 Manstein Jan 2018 B2
20010025190 Weber et al. Sep 2001 A1
20010029373 Baker et al. Oct 2001 A1
20020002392 Bernabei Jan 2002 A1
20020026188 Balbierz et al. Feb 2002 A1
20020038101 Avrahami et al. Mar 2002 A1
20020061589 King et al. May 2002 A1
20020087155 Underwood et al. Jul 2002 A1
20020091377 Anderson et al. Jul 2002 A1
20020111615 Cosman et al. Aug 2002 A1
20020115991 Edwards Aug 2002 A1
20020120260 Morris et al. Aug 2002 A1
20020120261 Morris et al. Aug 2002 A1
20020120263 Brown et al. Aug 2002 A1
20020128641 Underwood et al. Sep 2002 A1
20020138049 Allen et al. Sep 2002 A1
20020161357 Anderson et al. Oct 2002 A1
20020161362 Penny et al. Oct 2002 A1
20020173777 Sand Nov 2002 A1
20020173780 Altshuler et al. Nov 2002 A1
20020183742 Carmel et al. Dec 2002 A1
20020193833 Dimmer et al. Dec 2002 A1
20030009148 Hayakawa Jan 2003 A1
20030018374 Paulos Jan 2003 A1
20030028186 Kreindel Feb 2003 A1
20030040739 Koop Feb 2003 A1
20030078573 Truckai et al. Apr 2003 A1
20030120269 Bessette et al. Jun 2003 A1
20030125728 Nezhat et al. Jul 2003 A1
20030130655 Woloszko et al. Jul 2003 A1
20030144652 Baker et al. Jul 2003 A1
20030153960 Chornenky et al. Aug 2003 A1
20030173110 Gross et al. Sep 2003 A1
20030181965 Levy, Jr. et al. Sep 2003 A1
20030199868 Desai et al. Oct 2003 A1
20030208248 Carter et al. Nov 2003 A1
20030212394 Pearson et al. Nov 2003 A1
20030216719 Debenedictis et al. Nov 2003 A1
20030216729 Marchitto et al. Nov 2003 A1
20040019371 Jaafar et al. Jan 2004 A1
20040030332 Knowlton et al. Feb 2004 A1
20040039429 Daniel et al. Feb 2004 A1
20040048842 McMillan Mar 2004 A1
20040049251 Knowlton Mar 2004 A1
20040073079 Altshuler et al. Apr 2004 A1
20040073277 Geronemus et al. Apr 2004 A1
20040082940 Black et al. Apr 2004 A1
20040127895 Flock et al. Jul 2004 A1
20040137044 Stern et al. Jul 2004 A1
20040147964 Nolan et al. Jul 2004 A1
20040162551 Brown Aug 2004 A1
20040181216 Kelly et al. Sep 2004 A1
20040186470 Goble et al. Sep 2004 A1
20040206365 Knowlton Oct 2004 A1
20040220562 Garabedian et al. Nov 2004 A1
20040267335 Tulip et al. Dec 2004 A1
20050004567 Daniel et al. Jan 2005 A1
20050043726 McHale et al. Feb 2005 A1
20050049582 DeBenedictis et al. Mar 2005 A1
20050065510 Carmel et al. Mar 2005 A1
20050087198 Bruno-Raimondi et al. Apr 2005 A1
20050119605 Sohn Jun 2005 A1
20050137662 Morris et al. Jun 2005 A1
20050171534 Habib Aug 2005 A1
20050203575 Carson et al. Sep 2005 A1
20050209564 Bonner et al. Sep 2005 A1
20050209565 Yuzhakov et al. Sep 2005 A1
20050222555 Manstein et al. Oct 2005 A1
20050222565 Manstein Oct 2005 A1
20050260252 Levin et al. Nov 2005 A1
20050287217 Levin et al. Dec 2005 A1
20060004306 Altshuler et al. Jan 2006 A1
20060004347 Altshuler et al. Jan 2006 A1
20060009750 Altshuler et al. Jan 2006 A1
20060020309 Altshuler et al. Jan 2006 A1
20060025837 Stern et al. Feb 2006 A1
20060047281 Kreindel Mar 2006 A1
20060058712 Altshuler et al. Mar 2006 A1
20060074413 Behzadian Apr 2006 A1
20060079885 Rick et al. Apr 2006 A1
20060085048 Cory et al. Apr 2006 A1
20060122668 Anderson et al. Jun 2006 A1
20060155266 Manstein et al. Jul 2006 A1
20060206110 Knowlton et al. Sep 2006 A1
20060224148 Cho et al. Oct 2006 A1
20060253112 Suarez et al. Nov 2006 A1
20060293722 Slatkine et al. Dec 2006 A1
20070009542 Levin et al. Jan 2007 A1
20070010810 Kochamba Jan 2007 A1
20070010811 Stern et al. Jan 2007 A1
20070073367 Jones et al. Mar 2007 A1
20070106143 Flaherty May 2007 A1
20070125662 Dumont et al. Jun 2007 A1
20070129714 Elkins et al. Jun 2007 A1
20070141132 Sacks et al. Jun 2007 A1
20070142885 Hantash et al. Jun 2007 A1
20070173799 Hsia Jul 2007 A1
20070198003 Domankevitz et al. Aug 2007 A1
20070208340 Ganz et al. Sep 2007 A1
20070260170 Levin et al. Nov 2007 A1
20070270732 Levin et al. Nov 2007 A1
20070287949 Levin et al. Dec 2007 A1
20080015555 Manstein et al. Jan 2008 A1
20080021442 Manstein et al. Jan 2008 A1
20080082090 Manstein Apr 2008 A1
20080114281 Birchall et al. May 2008 A1
20080125775 Morris May 2008 A1
20080154254 Burger et al. Jun 2008 A1
20080172047 Altshuler et al. Jul 2008 A1
20080200910 Burger et al. Aug 2008 A1
20080221649 Echague et al. Sep 2008 A1
20080274166 Sacks et al. Nov 2008 A1
20080312647 Knopp et al. Dec 2008 A1
20090118698 Liebl May 2009 A1
20090124958 Li et al. May 2009 A1
20090299361 Flyash Dec 2009 A1
20100010480 Mehta Jan 2010 A1
20100010484 Mehta et al. Jan 2010 A1
20100023003 Mulholland Jan 2010 A1
20110046615 Manstein Feb 2011 A1
20120035608 Marchitto et al. Feb 2012 A1
20120158100 Schomacker Jun 2012 A1
20130274837 Nemati Oct 2013 A1
20160192961 Ginggen Jul 2016 A1
20160228178 Lei Aug 2016 A1
Foreign Referenced Citations (51)
Number Date Country
757624 Feb 2003 AU
2005231443 Oct 2005 AU
2005231443 Feb 2012 AU
2362276 Aug 2000 CA
2579145 Oct 2005 CA
19929713 Jan 2001 DE
0167662 Jan 1986 EP
0226336 Jun 1987 EP
1041933 Oct 2000 EP
1078648 Feb 2001 EP
178411 Sep 2012 IL
S5376589 Jun 1978 JP
S5436223 Mar 1979 JP
S6045616 Nov 1985 JP
H06190059 Jul 1994 JP
2000342617 Dec 2000 JP
2001510702 Aug 2001 JP
2001526077 Dec 2001 JP
2002291910 Oct 2002 JP
2003093521 Apr 2003 JP
4180285 Nov 2008 JP
4203224 Dec 2008 JP
1993-0007377 Aug 1993 KR
200187961 Jul 2000 KR
20010000523 Jan 2001 KR
200287997 Sep 2002 KR
200295277 Nov 2002 KR
9634568 Nov 1996 WO
9824509 Jun 1998 WO
9904710 Feb 1999 WO
9926546 Jun 1999 WO
0023143 Apr 2000 WO
0048644 Aug 2000 WO
0106943 Feb 2001 WO
0132073 May 2001 WO
0137728 May 2001 WO
02011624 Feb 2002 WO
02049711 Jun 2002 WO
02053050 Jul 2002 WO
02060523 Aug 2002 WO
02102265 Dec 2002 WO
03005919 Jan 2003 WO
03061497 Jul 2003 WO
03075978 Sep 2003 WO
03084398 Oct 2003 WO
2004086947 Oct 2004 WO
05007003 Jan 2005 WO
2005007001 Jan 2005 WO
2005096979 Oct 2005 WO
2005096980 Oct 2005 WO
05107848 Nov 2005 WO
Non-Patent Literature Citations (141)
Entry
Pearce (1986) Electrosurgery, Medical Instrumentation and Clinical Engineering Series, London: Chapman and Hall Medical (1986), 273 pages.
Pearce (Jun. 2001) “Corneal reshaping by radio frequency current: numerical model studies,” Thermal Treatment of Tissue: Energy Delivery and Assessment, Proceedings of SPIE, vol. 4247, pp. 109-118.
Pozner et al. (2002) “Nonablative Laser Resurfacing: State of the Art 2002,” Aesthetic Surgery Journal, Sep./Oct. 2002, vol. 22, No. 5, pp. 427-437.
Prieto et al. (2005) “Evaluation of pulsed light and radiofrequency combined for the treatment of acne vulgaris with histologic analysis of facial skin biopsies,” J. Cosmet. Laser Ther., vol. 7, pp. 63-68.
Ramaut et al. (2018) “Microneedling: Where do we stand now? A systematic review of the literature,” J. Plast. Reconstr. Aesthet. Surg., vol. 71, pp. 1-14.
Rosenbach (2000) “Coblation: A New Technique for Skin Resurfacing,” Aesthetic Surgery Journal, Jan./Feb. 2000, vol. 20, No. 1, pp. 81-83.
Ruiz-Esparza et al. (2003) “Nonablative radiofrequency for active acne vulgaris: the use of deep dermal heat in the treatment of moderate to severe active acne vulgaris (Thermotherapy): a report of 22 patients,” Dermatol. Surg., vol. 29, pp. 333-339.
Ruiz-Esparza (2006) “Nonablative radiofrequency for facial and neck rejuvenation. A faster, safer, and less painful procedure based on concentrating the heat in key areas; The ThermaLift concept.” J. Comset. Dermatol., vol. 5, pp. 68-75.
Sadick et al. (2004) “A prospective clinical study to evaluate the efficacy and safety of cellulite treatment using the combination of optical and RF energies for subcutaneous tissue heating.” J. Cosmet. Laser Ther., vol. 6, pp. 187-190.
Sadick et al. (2005) “Enhanced full-face skin rejuvenation using synchronous intense pulsed optical and conducted bipolar radiofrequency energy (ELOS): introducing selective radiophotothermolysis.” J. Drugs Dermatol., Mar./Apr. 2005, vol. 4, Issue 2, pp. 181-186.
Sarradet et al. (2003) “Electrosurgical resurfacing: a clinical, histologic, and electron microscopic evaluation,” Lasers Surg. Med., vol. 32, pp. 111-114.
Sukal et al. (2008) “Thermage: the nonablative radiofrequency for rejuvenation,” Clin. Dermatol., vol. 26, pp. 602-607.
Taheri et al. (2014) “Entrance and propagation pattern of high-frequency electrical currents in biological tissues as applied to fractional skin rejuvenation using penetrating electrodes.” Skin Res Technol., vol. 20, pp. 270-273.
Weiss et al. (2006) “Monopolar radiofrequency facial tightening: a retrospective analysis of efficacy and safety in over 60 treatments.” J. Drugs Dermatol., Sep. 2006, vol. 5, Issue 8, pp. 707-712.
Talk About Sleep (Apr. 2001) “Somnus Announces New Device for Turbinate Somnoplasty®,” Talk About Sleep, available at https://www.talkaboutsleep.com/somnus-announces-new-device-for- turbinate-somnoplasty/, 2 pges.
TransPharma Medical Ltd. (2003) “Technology—RF-MicroChannelTM Technology,” http://www.transpharma-medical.com:80/product_apps.html., 2 pages.
Tungjitkusolmun et al. (2000) “Thermal—electrical finite element modelling for radio frequency cardiac ablation: effects of changes in myocardial properties,” Med. Biol. Eng. Comput. vol. 38, pp. 562-568.
Tungjitkusolmun et al. (Feb. 2001) “Guidelines for Predicting Lesion Size at Common Endocardial Locations During Radio-Frequency Ablation,” IEEE Transactions on Biomedical Engineering, vol. 48, No. 2, pp. 194-201.
Tungjitkusolmun et al. (Jan. 2002) “Three-Dimensional Finite-Element Analyses for Radio-Frequency Hepatic Tumor Ablation,” IEEE Transactions on Biomedical Engineering, vol. 49, No. 1, pp. 3-9.
Turrell (Jan. 1935) “Discussion on Short-Wave Diathermy,” in Proceedings of the Royal Society of Medicine, Section of Physical Medicine, vol. 28, pp. 302-312.
Utley et al. (1999) “Radiofrequency Ablation of the Nerve to the Corrugator Muscle for Elimination of Glabellar Furrowing,” Archives of Facial Plastic Surgery, vol. 1, pp. 46-48.
Zelickson et al. (Feb. 2004) “Histological and Ultrastructural Evaluation of the Effects of a Radiofrequency-Based Nonablative Dermal Remodeling Device: A Pilot Study,” Acrhives of Dermatological Research, vol. 140, pp. 204-209.
U.S. Appl. No. 10/367,582, filed Nov. 20, 2003, 52 pages.
U.S. Appl. No. 60/258,855, filed Oct. 31, 2002, 45 pages.
U.S. Appl. No. 60/480,229, filed Nov. 22, 2007, 38 pages.
U.S. Appl. No. 60/486,304, filed Mar. 3, 2005, 54 pages.
Calderhead et al. (Jan. 2013) “The Clinical Efficacy and Safety of Microneedling Fractional Radiofrequency in the Treatment of Facial Wrinkles: A Multicenter Study With the Infini System in 499 Patients,” White paper, Lutronic Corp, Goyang, South Korea, 8 pages.
Cryomed (2016) “Micro-Needle Fractional RF System-Cryomed, Advanced Anti-Aging RF Technology,” http://cryomed.com.au/product/secret-rf/, 4 pages.
GBS Aesthetic Co. (2010) “Fractional Micro-Needle RF Skin Refining and Recovery System (RF-cell),” Copyright © 2010 gbsaesthetic, 2 pages.
PCT International Search Report, PCT/US2008/061682, dated Sep. 17, 2008, 3 pages.
PCT International Search Report, PCT/US2010/037950, dated Feb. 1, 2011, 7 pages.
PCT Written Opinion, PCT/US2010/037950, dated Feb. 1, 2011, 5 pages.
Harrington, A Review of IR Transmitting, Hollow Waveguides, Fiber and Integrated Optics, 2000, 19:211-217.
Khan, et al., Intradermally Focused Infrared Laser Pulses: Thermal Effects at Defined Tissue Depths, Lasers in Surgery and Medicine, 2005, 36:270-280.
Manstein, et al., Fractional Photothermolysis: A New Concept for Cutaneous Remodeling Using Microscopic Patterns of Thermal Injury, Lasers in Surgery and Medicine, 2004, 34:426-438.
Tschopp, et al., Comparison of Various Methods of Electromyographic Monitoring of the Recurrent Laryngeal Nerve in Thyroid Surgery, Annals of Otology, Rhinology & Laryngology, 2002, 111(9):811-816.
Urmey, et al., Percutaneous Electrode Guidance: A Noninvasive Technique for Prelocation of Peripheral Nerves to Facilitate Peripheral Plexus or Nerve Block, Regional Anesthesia & Pain Medicine, 2002, 27(3):261-267.
Schott North America Inc., Medical Fiber Optic Components, Hightech Solutions for Health, Product Brochure, 2003, 20 pages.
Deka M.E.L.A. s.r.l., Smartlipo Nd:YAG Laser System for Laserlipolisi, Product Brochure, Copyright Deka 003-8018-04-020 Rev. 1.3, 2 pages.
Deka M.E.L.A. s.r.l., Tri-Active Product Brochure, Copyright Deka 003-8010-04-020 Rev. 2.1, 4 pages.
Lutronic, Infini High Intensity Focused RF, Brochure, 5 pages (From Annex to the Communication of the Minutes of the Oral Proceeding of European Application 05733209.0, dated Mar. 5, 2016).
“Non-Surgical Facelift Erases Some Wrinkles, Sagging,” ABC News, Nov. 18, 2003.
Aksan et al. (2002) “Heat-Induced Denaturation of Collagenous Tissue: A Comparison of Numerical Simulations With OCT and MRI Data,” ASME 2002 International Mechanical Engineering Congress and Exposition, pp. 51-54.
Alexiades-Armenakas et al. (2008) “Unipolar Versus Bipolar Radiofrequency Treatment of Rhytides and Laxity Using a Mobile Painless Delivery Method,” Lasers in Surgery and Medicine, vol. 40, pp. 446-453.
Anastassakis, (2005 or later) “The Dermaroller Series,” 14 pages.
Anderson et al. “Selective Photothermolysis: Precise Microsurgery by Selective Absorption of Pulsed Radiation,” Science, vol. 220, No. 4596, Apr. 29, 1983, pp. 524-527.
Anderson et al. (Jul. 1989) “Selective Photothermolysis of Cutaneous Pigmentation by Q-switched Nd: YAG Laser Pulses at 1060, 532, and 355 nm,” The Journal of Investigative Dermatology, vol. 93, No. 1, pp. 28-32.
Amoczky and Aksan (Sep./Oct. 2000) “Thermal Modification of Connective Tissues: Basic Science Considerations and Clinical Implications,” J. Am. Acad. Orthop. Surg., vol. 8, No. 5, pp. 305-313.
Berube (2015) “Real-time Temperature Feedback for Clinical Reproducibility: The Mechanism of Action of Profound,” Syneron Candela, 5 pages.
Berube et al. (2009) “A Predictive Model of Minimally Invasive Bipolar Fractional Radiofrequency Skin Treatment,” Lasers in Surgery and Medicine, vol. 41, pp. 473-478.
Bums et al. (1999) “Electrosurgical Skin Resurfacing: A New Bipolar Instrument,” Dermatologic Surgery, vol. 25, No. 7, pp. 582-586.
Camirand and Doucet (1997) “Needle Dermabrasion,” Aesth. Plast. Surg., vol. 21, pp. 48-51.
Capon and Mordon (2003) “Can Thermal Lasers Promote Skin Wound Healing?” Am. J. Dermatol., vol. 4, No. 1, pp. 1-12.
Chang “Finite Element Analysis of Hepatic Radiofrequency Ablation Probes using Temperature-Dependent Electrical Conductivity,” BioMedical Engineering Online, vol. 2, No. 1, p. 1, May 8, 2003, 18 pages.
Chang et al. “Thermal modeling of lesion growth with radiofrequency ablation devices,” BioMedical Engineering Online, vol. 3, No. 1, p. 1, Aug. 6, 2004, 19 pages.
Chen et al. (Jun. 2003) “Acupuncture, Electrostimulation and Reflex Therapy in Dermatology,” Dermatologic Therapy, vol. 16, pp. 87-92.
Cosman (1983) “Stereotactic Radiofrequency Lesion Making,” Proc. Am. Stereotactic and Functional Neurosurg., vol. 46, pp. 160-166.
Derma Roller Store “The History of the Derma Roller,” available for download at https://www.dermarollerstore.co.uk/history-derma-roller/, Jun. 19, 2017, 9 pages.
Ellis (1947) “Electrolysis Versus High Frequency Currents in the Treatment of Hypertrichosis: A Comparative Histologic and Clinical Study,” Arch. Derm. Syphilol., vol. 56, No. 3, pp. 291-305.
Fisher et al. (Sep. 2005) “Nonablative Radiofrequency Treatment of Facial Laxity,” Dermatol. Surg., vol. 31, 1237-1241.
Fitzpatrick et al. (Oct. 2003) “Multicenter Study of Noninvasive Radio Frequency for Periorbital Tissue Tightening,” Lasers in Surgery and Medicine, vol. 33, pp. 232-242.
Goats (1989) “Continuous Short-Wave (Radio-Frequency) Diathermy,” Br. J. Sp. Med., vol. 23, No. 2, pp. 123-127.
Gold (Jan. 2010) “Update on Fractional Laser Technology,” J. Clin. Aesthet. Dermatol., vol. 3, No. 1, pp. 42-50.
Goode (2002) “Current Status of Radio-Frequency Technology in the Treatment of Head and Neck Disease,” Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems XII, Proceedings of SPIE, vol. 4609, pp. 291-294_.
Griss et al. (Jan. 2000) “Spiked Biopotential Electrodes,” Proceedings IEEE Thirteenth Annual International Conference on Micro Electro Mechanical Systems, pp. 323-328.
Haemmerich et al. (Oct. 2001) “Hepatic Bipolar Radio-Frequency Ablation Between Separated Multiprong Electrodes,” IEEE Transactions on Biomedical Engineering, vol. 48, No. 10, pp. 1145-1152.
Hantash et al. (2009) “Bipolar Fractional Radiofrequency Treatment Induces Neoelastogenesis and Neocollagenesis,” Lasers in Surfery and Medicine, vol. 41, pp. 1-9.
Hantash et al. (2009) “Pilot Clinical Study of a Novel Minimally Invasive Bipolar Microneedle Radiofrequency Device,” Lasers in Surgery and Medicine, vol. 41, pp. 87-95.
Henry et al. (Aug. 1998) “Microfabricated Microneedles: A Novel Approach to Transdermal Drug Delivery,” J. Pharma Sci. vol. 87, No. 8, pp. 922-925.
Henry et al. (Jan. 1998) “Micromachined Needles for the Transdermal Delivery of Drugs,” Proceedings MEMS 98. IEEE. Eleventh Annual International Workshop on Micro Electro Mechanical Systems, pp. 494-498.
Hruza et al. (Mar. 2009) “Skin Rejuvenation and Wrinkle Reduction Using a Fractional Radiofrequency System,” Journal of Drugs in Dermatology, vol. 8, No. 3, pp. 259-265.
Hsu et al. (Jun. 2003) “The Use of Nonablative Radiofrequency Technology to Tighten the Lower Face and Neck,” Seminars in Cutaneous Medicine and Surgery, vol. 22, No. 2, pp. 115-123.
Ito et al. (Dec. 2003) “Temperature Distribution in and Around Array Applicator for Interstitial Microwave Hyperthermia Combined With Interstitial Radiation Therapy,” available at https://www.researchgate.net/publication/228692748, 4 pages.
Jih et al. (Mar. 2008) “Fractional Photothermolysis: A Review and Update,” Seminars in Cutaneous Medicine and Surgery, vol. 27, No. 1, pp. 63-71.
Kahrilas (2003) “Radiofrequency Therapy of the Lower Esophageal Sphincter for Treatment of GERD,” Gastrointestinal Endoscopy, vol. 57, No. 6, pp. 723-731.
Lencioni et al.(2001) Percutaneous Radiofrequency Thermal Ablation of Liver Malignancies: Techniques, Indications, Imaging Findings, and Clinical Results, Abdominal Imaging, vol. 26, pp. 345-360.
Lodhi et al. (2003) “Erbium:YAG Laser Skin Resurfacing: a Pakistani Experience,” J. Cosmetic & Laser Ther., vol. 5, pp. 43-47.
Mancini (2001) “Coblation: A New Technology and Technique for Skin Resurfacing and Other Aesthetic Surgical Procedures,” Aesthetic Plastic Surgery, vol. 25, No. 5, pp. 372-377.
McGahan et al. (1995) “Percutaneous Ultrasound-Guided Radiofrequency Electrocautery Ablation of Prostate Tissue in Dogs,” Academic Radiology, vol. 2, pp. 61-65.
Medical Insight, Inc. (Mar.-Apr. 2004) Fractional Photothermolysis Redefines Facial Skin Regeneration Science, Medical Insight, Inc., Aesthetic Buyers Guide Mar.-Apr. 2004, 4 pages.
Millard et al. (1996) “A study of the Efficacy and Safety of Transurethral Needle Ablation (TUNA®) Treatment for Benign Prostatic Hyperplasia,” Neurourology and Urodynamics, vol. 15, pp. 619-629.
Milner et al. (1997) “Analysis of Nonablative Skin Resurfacing,” Proceedings of SPIE—The International Society for Optical Engineering, vol. 2970, pp. 367-372.
Moritz et al. (1947) “The Relative Importance of Time and Surface Temperature in the Causation of Cutaneous Bums,” The American Journal of Pathology, vol. 23, No. 5, pp. 695-720.
Narins et al. (Oct. 2003) “Non-Surgical Radiofrequency Facelift,” Journal of Drugs in Dermatology, vol. 2, No. 5, pp. 495-500.
Orentreich and Orentreich (1995) “Subcutaneous Incisionless (Subscision) Surgery for the Correction of Depressed Scars and Wrinkles” Dermatol. Surg., vol. 21, pp. 543-549.
Pham et al. (Sep. 2003) “3D Finite Element Model of RF Heating: Novel Non-Ablative Cutaneous Therapy,” in Proceedings of SPIE (The International Society for Optical Engineering): Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems XIII, vol. 4949, pp. 22-31.
Sadick et al. (2004) “Selective Electro-Thermolysis in Aesthetic Medicine: A Review,” Lasers in Surgery and Medicine, vol. 34, pp. 91-97.
Schramm et al. (2007) “Contribution of Direct Heating, Thermal Conduction and Perfusion During Radiofrequency and Microwave Ablation,” The Open Biomedical Engineering Journal, vol. 1, pp. 47-52.
Sebben (1989) “Monopolar and Bipolar Treatment,” Journal of Dermatologic Surgery and Oncology, vol. 15, No. 4, pp. 364-366.
Sintov et al. (2003) “Radiofrequency-Driven Skin Microchanneling as a New Way for Electrically Assisted Transdermal Delivery of Hydrophilic Drugs,” Journal of Controlled Release, vol. 89, pp. 311-320.
Takahashi et al. (Jul. 2002) “Radio-Frequency Energy Delivery to the Anal Canal for the Treatment of Fecal Incontinence,” Diseases of the Colon & Rectum, vol. 45, No. 7, pp. 915-922.
Abraham et al. (2005) “Current concepts in nonablative radiofrequency rejuvenation of the lower face and neck,” Facial. Plast. Surg., vol. 21, pp. 65-73.
Alexiades-Armenakas, et al. (Aug. 2004) “The Safety and Efficacy of the 308-nm Excimer Laser Pigment Correction of Hypopigmented Scars and Striae Alba,” Arch. Dermatol., vol. 140, pp. 955-960.
Alexiades-Armenakas et al. (2008) “Unipolar radiofrequency treatment to improve the appearance of cellulite,” Journal of Cosmetic and Laser Therapy, vol. 10, pp. 148-153.
Alexiades-Armenakas et al. (2013) “Prospective multicenter clinical trial of a minimally invasive temperature-controlled bipolar fractional radiofrequency system for rhytid and laxity treatment,” Dermatol. Surg., vol. 39, No. 2, pp. 263-273.
Alster et al. (2004) “Improvement of neck and cheek laxity with a nonablative radiofrequency device: a lifting experience,” Dermatol. Surg., vol. 30, pp. 503-507.
Alster et al. (2005) “Cellulite treatment using a novel combination radiofrequency, infrared light, and mechanical tissue manipulation device.” J Cosmet Laser Ther 2005;7:81-85.
Alster et al. (2007) “Nonablative cutaneous remodeling using radiofrequency devices,” Clin. Dermatol., vol. 25, pp. 487-491.
Atiyeh et al. (2009) “Nonsurgical nonablative treatment of aging skin: radiofrequency technologies between aggressive marketing and evidence-based efficacy,” Aesth. Plast. Surg., vol. 33, pp. 283-294.
Bassichs et al. (2004) “Use of a nonablative radiofrequency device to rejuvenate the upper one-third of the face,” Otolaryngol. Head Neck Surg., vol. 130, No. 4, pp. 397-406.
Bedi et al. (2007) “The Effects of Pulse Energy Variations on the Dimensions of Microscopic Thermal Treatment Zones in Nonablative Fractional Resurfacing,” Lasers Surg. Med., vol. 39, pp. 145-155.
Biesman et al. (2007) “Monopolar radiofrequency treatment of the eyelids: a safety evaluation,” Dermatol. Surg., vol. 33, pp. 794-801.
Cachafeiro et al. (2016) “Comparison of Nonablative Fractional Erbium Laser 1,340 nm and Microneedling for the Treatment of Atrophic Acne Scars: A Randomized Clinical Trial.” Dermatol. Surg., vol. 42, No. 2, pp. 232-241.
Carniol et al. (2001) “Bipolar radiofrequency resurfacing.” Facial Plast. Surg. Clin. North Am., vol. 9, No. 3, pp. 337-342.
Carruthers (2001) “Radiofrequency resurfacing: technique and clinical review,” Facial. Plast. Surg. Clin. North Am., vol. 9, No. 2, pp. 311-319.
Dahan et al. (2013) “Multisource radiofrequency for fractional skin resurfacing-significant reduction of wrinkles.” J. Cosmet. Laser Ther., vol. 15, No. 2, pp. 91-97.
Del Pino et al. (2006) “Effect of controlled volumetric tissue heating with radiofrequency on cellulite and the subcutaneous tissue of the buttocks and thighs,” J. Drugs Dermatol., vol. 5, pp. 714-722.
Doddaballapur (2009) “Microneedling with dermaroller.” J. Cutan. Aesthet. Surg. vol. 2, No. 2, pp. 110-111.
Doshi et al. (2005) “Combination radiofrequency and diode laser for treatment of facial rhytides and skin laxity.” J. Cosmet. Laser Ther. vol. 7, pp. 11-15.
El-Domyati et al. (2010) “Electro-optical synergy technique. A new and effective nonablative approach to skin aging.” J. Clin. Aesthet. Dermatol., vol. 3, No. 12, pp. 22-30.
El-Domyati et al. (2011) “Radiofrequency facial rejuvenation: evidence-based effect,” J. Am. Acad. Dermatol., vol. 64, No. 3, pp. 524-535.
Elman et al. (2011) “Novel multi-source phase-controlled radiofrequency technology for non-ablative and micro-ablative treatment of wrinkles, lax skin and acne scars.” Laser. Ther., vol. 20, No. 2, pp. 139-144.
Elsaie (2009) “Cutaneous remodeling and photorejuvenation using radiofrequency devices,” Indian J. Dermatol., vol. 54, No. 3, pp. 201-205.
Fisher et al. (2005) “Short-term side effects of fractional photothermolysis,” Dermatol. Surg. vol. 31, pp. 1245-1249; discussion 1249.
Gold et al. (2007) “Treatment of wrinkles and elastosis using vacuum-assisted bipolar radiofrequency heating of the dermis.” Dermatol. Surg., vol. 33, pp. 300-309.
Goldberg et al. (2008) “Clinical, laboratory, and MRI analysis of cellulite treatment with a unipolar radiofrequency device,” Dermatol. Surg. vol. 34, pp. 204-209.
Grekin et al. (2000) “Electrosurgical facial resurfacing: a prospective multicenter study of efficacy and safety,” Arch. Dermatol., vol. 136, pp. 1309-1316.
Hammes et al. (2006) “Electro-optical energy (ELOS) technology for nonablative skin rejuvenation: a preliminary prospective study.” J Eur Acad Dermatol Venereol, vol. 20, pp. 1070-1075.
Hantash et al. (2006) “Ex vivo histological characterization of a novel ablative fractional resurfacing device,” Lasers Surg. Med., pp. 1-9.
Hantash et al. (Aug. 2006) “Facial resurfacing for nonmelanoma skin cancer prophylaxis,” Arch. Dermatol., vol. 142, No. 8, pp. 976-982.
Hantash et al. (2006) “Laser-induced transepidermal elimination of dermal content by fractional photothermolysis” Thorned. Opt., (Jul./Aug. 2006) vol. 11, No. 4, pp. 041115-1-041115-9.
Hantash et al. (2007) “Fractional photothermolysis: a novel aesthetic laser surgery modality,” Dermatol. Surg., vol. 33, No. 5, pp. 1-10.
Hantash et al. (2007) “In Vivo Histological Evaluation of a Novel Ablative Fractional Resurfacing Device,” Lasers Surg. Med., vol. 39, pp. 96-107.
Hantash et al. (2012) “Laser Skin Tightening: Nonablative Skin Rejuvenation.” In: Non-Invasive Cosmetic Procedures: Thomas Procedures in Facial Plastic Surgery (Koch, R.J., ed.) People's Medical Publishing House—USA, Shelton, Connecticut, pp. 55-62.
Harth et al. (2013) “In vivo histological evaluation of non-insulated microneedle radiofrequency applicator with novel fractionated pulse mode.” J. Drugs Dermatol., vol. 12, No. 12, pp. 1430-1433.
Jacobson et al. (2003) “Treatment of nasolabial folds and jowls with a noninvasive radiofrequency device,” Arch. Dermatol., vol. 139, pp. 1371-1372.
Javate et al. (2011) “Nonablative 4-MHz dual radiofrequency wand rejuvenation treatment for periorbital rhytides and midface laxity.” Ophthal. Plast. Reconstr. Surg., vol. 27, No. 3, pp. 180-185.
Khan et al. (2010) “Treatment of cellulite. Part II. Advances and controversies,” J Am. Acad. Dermatol., vol. 62, No. 3, pp. 373-384.
Koch (2000) Dr. R. James Koch, MD, The Latest Advances in Facial Plastic Surgery, San Francisco, CA (2000).
Koch (2001) Dr. R. James Koch, MD, Non-Ablative Skin Tightening: Why? at Controversies in Facial Plastic Surgery, Key Largo, Fl. (2001).
Koch (2002) Dr. R. James Koch, MD, Experience with ThermaCool Soft Tissue Tightening, The UCLA Minimally Invasive Aesthetic Surgery of the Face Course: A Multi-Disciplinary Course, Mauna Lani, Hawaii, (2002).
Koch (2003) Dr. R. James Koch, MD, Non-Invasive Treatment of Facial Rhytids: AO ASIF Cosmetic Facial Surgery, Challenges and Advances in the Management of Craniomaxillofacial Surgery, San Francisco, California (2003).
Koch (2004) “Radiofrequency Nonablative Tissue Tightening.” Facial Plast. Surg. Clin. North Am., vol. 12, No. 3, pp. 339-346.
Koch (2009) “Radiofrequency Tissue Tightening.” In: Non-Invasive Cosmetic Procedures: Thomas Procedures in Facial Plastic Surgery (Koch, R.J., ed.) People's Medical Publishing House—USA, Shelton, Connecticut, pp. 63-67.
Koch et al. (2012) “Radiofrequency Tissue Tightening.” In: Non-Invasive (Koch, R.J., ed.). In: Fundamentals in Facial Plastic Surgery (Thomas, Jr., ed.) New York, People's Medical Publishing House, pp. 63-67.
Kulick et al. (2005) “Evaluation of a combined laser-radio frequency device (Polaris WR) for the nonablative treatment of facial wrinkles.” J. Cosmet. Laser. Ther., vol. 7, pp. 87-92.
Laubach et al. (Feb. 2006) “Skin Responses to Fractional Photothermolysis,” Lasers in Surgery and Medicine, vol. 38, No. 2, pp. 142-149.
Lu et al. (2001) “Effect of bipolar radiofrequency energy on human articular cartilage: Comparison of confocal laser microscopy and light microscopy.” Arthroscopy: The Journal of Arthroscopic and Related Surgery, vol. 17, No. 2, pp. 117-123.
Min et al. (2015) “Comparison of fractional microneedling radiofrequency and bipolar radiofrequency on acne and acne scar and investigation of mechanism: comparative randomized controlled clinical trial,” Arch. Dermatol. Res., vol. 307, No. 10, pp. 897-904.
Montesi et al. (2007) “Bipolar radiofrequency in the treatment of dermatologic imperfections: clinicopathological and immunohistochemical aspects.” J. Drugs Dermatol., vol. 6, Issue 9, pp. 890-896.
Nahm et al. (2004) “Objective changes in brow position, superior palpebral crease, peak angle of the eyebrow, and owl surface area after volumetric radiofrequency treatments to half of the face.” Dermatol. Surg., vol. 30, pp. 922-928.
Related Publications (1)
Number Date Country
20180221083 A1 Aug 2018 US
Provisional Applications (1)
Number Date Country
60558476 Apr 2004 US
Divisions (1)
Number Date Country
Parent 11098030 Apr 2005 US
Child 12914201 US
Continuations (3)
Number Date Country
Parent 15844597 Dec 2017 US
Child 15941139 US
Parent 14725976 May 2015 US
Child 15844597 US
Parent 12914201 Oct 2010 US
Child 14725976 US